PF-AtlasDrugs › Synrinse

Synrinse

Idiopathic Pulmonary Fibrosis

Clinical trials
1
Developer
University of Washington

Overview

Synrinse is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.

Synrinse clinical trials

Explore related

Medical disclaimer. This page summarizes research about Synrinse for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.